Holen Sie sich die Stockscreener-App
48.59
0.51%
-0.25
Handel nachbörslich:
48.00
-0.59
-1.21%
Finanzdaten der Ptc Therapeutics Inc-Aktie (PTCT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
31.57%
210.12
|
307.06 | 196.58 | 213.81 | 220.38 |
Operating Expenses
|
15.16%
255.57
|
301.24 | 314.74 | 423.35 | 338.00 |
| Benefits Costs and Expenses |
36.48%
294.81
|
464.11 | 363.17 | 451.29 | 355.37 |
| Costs And Expenses |
36.48%
294.81
|
464.11 | 363.17 | 451.29 | 355.37 |
| Operating Income/Loss |
880.98%
-45.45
|
5.82 | -118.16 | -209.54 | -117.61 |
| Income/Loss From Continuing Operations Before Tax |
46.07%
-84.70
|
-157.05 | -166.59 | -237.48 | -134.99 |
| Income Tax Expense/Benefit, Deferred |
100.03%
-0.001
|
3.979 | -0.002 | -50.90 | -0.004 |
| Income Tax Expense/Benefit |
646.47%
6.88
|
-1.259 | -33.62 | -38.60 | 3.969 |
| Income/Loss From Continuing Operations After Tax |
41.22%
-91.58
|
-155.79 | -132.97 | -198.88 | -138.96 |
|
Net Income/Loss
|
41.22%
-91.58
|
-155.79 | -132.97 | -198.88 | -138.96 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
34,706%
76.50
|
0.2198 | 75.38 | 74.73 | 73.73 |
| Diluted Average Shares |
34,706%
76.50
|
0.2198 | 75.38 | 74.73 | 73.73 |
| Basic Earnings Per Share |
41.75%
-1.20
|
-2.06 | -1.76 | -2.66 | -1.88 |
| Diluted Earnings Per Share |
41.75%
-1.20
|
-2.06 | -1.76 | -2.66 | -1.88 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.39%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):